Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

Nuvo Research, Inc. (NRI.TO)

-Toronto
5.39 Down 0.02(0.37%) Sep 2, 3:59PM EDT
Add to Portfolio
Prev Close:5.41
Open:5.56
Bid:5.35
Ask:5.35
1y Target Est:N/A
Beta:0.349724
Earnings Date:Nov 9 - Nov 13 (Est.)
Day's Range:5.35 - 5.57
52wk Range:3.50 - 10.36
Volume:3,150
Avg Vol (3m):25,566
Market Cap:58.84M
P/E (ttm):1.57
EPS (ttm):3.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc., a specialty pharmaceutical company, researches, develops, and commercializes pharmaceutical products in Europe, Asia, and South America. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback